Petrus Trust Company LTA Purchases 8,398 Shares of Addus HomeCare Corporation $ADUS

Key Points

• Petrus Trust Company LTA significantly increased its stake in Addus HomeCare by 494.6%, owning 10,096 shares valued at approximately $998,000.
• Wall Street analysts generally view Addus HomeCare positively, with several firms upgrading their ratings and setting target prices between $133.00 and $150.00.
• Addus HomeCare reported a quarterly earnings per share of $1.49, surpassing estimates, while its revenue grew 21.8% year-over-year to $349.44 million.

Petrus Trust Company LTA lifted its position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 494.6% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,096 shares of the company's stock after acquiring an additional 8,398 shares during the period. Petrus Trust Company LTA owned 0.05% of Addus HomeCare worth $998,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in ADUS. BI Asset Management Fondsmaeglerselskab A S bought a new position in Addus HomeCare in the first quarter worth $41,000. Caitong International Asset Management Co. Ltd increased its stake in shares of Addus HomeCare by 368.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company's stock worth $124,000 after acquiring an additional 987 shares in the last quarter. Bailard Inc. bought a new position in shares of Addus HomeCare in the 1st quarter worth about $208,000. Heritage Family Offices LLP lifted its position in Addus HomeCare by 6.3% during the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock valued at $239,000 after acquiring an additional 143 shares during the period. Finally, Private Advisor Group LLC boosted its stake in Addus HomeCare by 52.4% during the first quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock worth $252,000 after acquiring an additional 875 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the business's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the completion of the sale, the chief executive officer owned 166,461 shares of the company's stock, valued at approximately $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Veronica Hill-Milbourne sold 1,571 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total value of $180,555.03. Following the completion of the transaction, the director directly owned 5,067 shares in the company, valued at $582,350.31. This trade represents a 23.67% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,310 shares of company stock worth $3,958,375 in the last 90 days. 4.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on ADUS shares. Macquarie reaffirmed an "outperform" rating and set a $133.00 target price on shares of Addus HomeCare in a research note on Tuesday, June 10th. TD Cowen raised their price objective on Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a research report on Wednesday, August 6th. Barclays boosted their target price on Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a report on Tuesday, August 19th. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. Finally, Royal Bank Of Canada increased their target price on Addus HomeCare from $133.00 to $134.00 and gave the company an "outperform" rating in a research note on Friday, August 22nd. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $138.89.

Addus HomeCare Stock Performance

Shares of ADUS traded up $2.00 during trading hours on Thursday, hitting $112.27. The stock had a trading volume of 106,309 shares, compared to its average volume of 186,603. The firm has a market capitalization of $2.07 billion, a PE ratio of 24.78, a PEG ratio of 1.72 and a beta of 0.85. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $136.72. The stock has a fifty day moving average price of $112.00 and a 200 day moving average price of $107.02.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, beating analysts' consensus estimates of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.Addus HomeCare's revenue was up 21.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.35 earnings per share. Analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.